(Q45370632)

13 December 2017

0 references

Evaluation of combination therapy against hepatitis C virus infection in human liver chimeric mice (English)

1 reference

13 December 2017

1 reference

2

Charles M Rice

1 reference

13 December 2017

3

Alexander Ploss

1 reference

13 December 2017

Ype P de Jong

1

1 reference

13 December 2017

publication date

25 October 2010

1 reference

13 December 2017

published in

Journal of Hepatology

1 reference

13 December 2017

volume

54

1 reference

13 December 2017

issue

5

1 reference

13 December 2017

page(s)

848-850

1 reference

Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment

13 December 2017

cites work

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2010.09.034

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2010.09.034

Robust Antiviral Efficacy upon Administration of a Nucleoside Analog to Hepatitis C Virus-Infected Chimpanzees

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2010.09.034

New horizons for studying human hepatotropic infections

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2010.09.034

Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha-2b plus ribavirin

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2010.09.034

Repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2010.09.034

Elimination of hepatitis C virus by short term NS3-4A and NS5B inhibitor combination therapy in human hepatocyte chimeric mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2010.09.034

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2010.09.034

Hepatitis C virus replication in mice with chimeric human livers

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2010.09.034

Optimizing the treatment of chronic viral hepatitis C.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2010.09.034

Telaprevir and peginterferon with or without ribavirin for chronic HCV infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2010.09.034

Near completely humanized liver in mice shows human-type metabolic responses to drugs

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2010.09.034

Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2010.09.034

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2010.09.034

Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2010.09.034

Identifiers

DOI

10.1016/J.JHEP.2010.09.034

1 reference

13 December 2017

1 reference